An enhanced artificial intelligence breast MRI interpretation system
Research type
Research Study
Full title
A comparative single-centre study to evaluate an enhanced artificial intelligence breast MRI interpretation system in women over 20 with breast lesions
IRAS ID
258617
Contact name
Susann Wolfram
Contact email
Sponsor organisation
Teesside University
Eudract number
2019-000067-25
Clinicaltrials.gov Identifier
Duration of Study in the UK
1 years, 3 months, 31 days
Research summary
Breast cancer is the most common type of cancer in women worldwide, with nearly 1.7 million new cases diagnosed in 2015. In the UK, one in five cases of breast cancer results in a fatality.
The IntelliScan project aims to develop a technological solution that addresses a significant healthcare challenge in the UK. IntelliScan will develop a software system that will be able to interpret breast MR images automatically in order to identify potential breast cancers. In this first study, the system's user interface as well as the breast MRI interpretation algorithm will be developed using existing MRI scans. Existing MRI scans with known breast anomalies will be used as training dataset to develop the decision-making basis for the algorithm. The system will then be tested using existing MRI scans without information about possible anomalies and results will be compared to results from the software system currently in use. In addition, the user-friendliness of the system's user interface will also be evaluated.
REC name
North West - Greater Manchester South Research Ethics Committee
REC reference
19/NW/0257
Date of REC Opinion
24 Jun 2019
REC opinion
Further Information Favourable Opinion